179 related articles for article (PubMed ID: 20616686)
21. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
24. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
[TBL] [Abstract][Full Text] [Related]
26. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema.
Tanito M; Hara K; Takai Y; Matsuoka Y; Nishimura N; Jansook P; Loftsson T; Stefánsson E; Ohira A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7944-8. PubMed ID: 21896859
[TBL] [Abstract][Full Text] [Related]
27. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
[TBL] [Abstract][Full Text] [Related]
28. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema.
Haller JA; Dugel P; Weinberg DV; Chou C; Whitcup SM
Retina; 2009 Jan; 29(1):46-51. PubMed ID: 18827732
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
Soheilian M; Karimi S; Ramezani A; Peyman GA
Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
Lee H; Kang KE; Chung H; Kim HC
Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
[TBL] [Abstract][Full Text] [Related]
33. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
Kim SJ; Equi R; Bressler NM
Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
[TBL] [Abstract][Full Text] [Related]
34. Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
Shen BY; Punjabi OS; Lowder CY; Sears JE; Singh RP
Retina; 2013 Apr; 33(4):873-7. PubMed ID: 23407350
[TBL] [Abstract][Full Text] [Related]
35. Hemodialysis-induced alterations in macular thickness measured by optical coherence tomography in diabetic patients with end-stage renal disease.
Theodossiadis PG; Theodoropoulou S; Neamonitou G; Grigoropoulos V; Liarakos V; Triantou E; Theodossiadis GP; Vlahakos DV
Ophthalmologica; 2012; 227(2):90-4. PubMed ID: 21921588
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Khurana RN; Palmer JD; Porco TC; Wieland MR
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):56-61. PubMed ID: 25559510
[TBL] [Abstract][Full Text] [Related]
40. Adverse events after intravitreal infliximab (Remicade).
Giganti M; Beer PM; Lemanski N; Hartman C; Schartman J; Falk N
Retina; 2010 Jan; 30(1):71-80. PubMed ID: 19996827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
